GL Pharm Tech Corp. (KOSDAQ:A204840) agreed to acquire remaining 67.91% stake in Crown Pharm Co., Ltd. for KRW 3 billion on January 24, 2018. GL Pharm Tech Corp. will acquire 0.11 million shares. GL Pharm Tech Corp. deposited KRW 300 million on January 24, 2018 and will pay balance of KRW 2.74 billion on January 26, 2018. Upon completion, GL Pharm Tech Corp's stake in Crown Pharm Co., Ltd. will increase to 100%. The scheduled acquisition date is January 26, 2018. Hyorim Accounting Corporation acted as external rating institution. GL Pharm Tech Corp. (KOSDAQ:A204840) completed the acquisition of remaining 67.91% stake in Crown Pharm Co., Ltd. on January 26, 2018. The balance consideration was paid on January 26, 2018. The Board of Directors of GL Pharm Tech Corp. passed a resolution on the transaction on January 24, 2018.